دورية أكاديمية
Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment
| العنوان: | Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment |
|---|---|
| المؤلفون: | Wiesmann, Frank, Naeth, Gudrun, Berger, Annemarie, Hirsch, Hans H., Regenass, Stephan, Roß, Rudolf Stefan, Sarrazin, Christoph, Wedemeyer, Heiner, Knechten, Heribert, Braun, Patrick |
| سنة النشر: | 2017 |
| المجموعة: | Publication Server of Goethe University Frankfurt am Main |
| مصطلحات موضوعية: | ddc:610 |
| الوصف: | An accurate quantification of low viremic HCV RNA plasma samples has gained importance since the approval of direct acting antivirals and since only one single measurement predicts the necessity of a prolonged or shortened therapy. As reported previously, HCV quantification assays such as Abbott RealTime HCV and Roche COBAS AmpliPrep/COBAS TaqMan HCV version 2 (CTM v2) may vary in sensitivity and precision particularly in low-level viremia. Importantly, substantial variations were previously demonstrated between some of these assays compared to the Roche High Pure System/COBAS TaqMan assay (HPS) reference assay, which was used to establish the clinical decision points in clinical studies. In this study, the reproducibility of assay performances across several laboratories was assessed by analysing quantification results generated by six independent laboratories (3× RealTime, 3× CTM v2) in comparison with one HPS reference laboratory. The 4th WHO Standard was diluted to 100, 25 and 10 IU/ml, and aliquots were tested in triplicates in 5 independent runs by each assay in the different laboratories to assess assay precision and detection rates. In a second approach, 2 clinical samples (GT 1a & GT 1b) were diluted to 100 and 25 IU/ml and tested as described above. While the result range for WHO 100 IU/ml replicates across all laboratories was similar in this analysis, the CVs of each laboratory ranged from 19.3 to 25.6 % for RealTime laboratories and were lower than CVs of CTM v2 laboratories with a range of 26.1–47.3 %, respectively, and also in comparison with the CV of the HPS reference laboratory (34.9 %). At WHO standard dilution of 25 IU/ml, 24 replicates were quantified by RealTime compared to 8 replicates with CTM v2. Results of clinical samples again revealed a higher variation of CTM v2 results as compared to RealTime values. (CVs at 100 IU/ml: RealTime: 13.1–21.0 % and CTM v2: 15.0–32.3 %; CVs at 25 IU/ml: RealTime 17.6–34.9 % and CTM v2 28.2–54.9 %). These findings confirm the superior precision of ... |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | English |
| العلاقة: | http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/43016Test; urn:nbn:de:hebis:30:3-430163; https://nbn-resolving.org/urn:nbn:de:hebis:30:3-430163Test; https://doi.org/10.1007/s00430-015-0443-9Test; http://publikationen.ub.uni-frankfurt.de/files/43016/430_2015_Article_443.pdfTest |
| DOI: | 10.1007/s00430-015-0443-9 |
| الإتاحة: | https://doi.org/10.1007/s00430-015-0443-9Test http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/43016Test https://nbn-resolving.org/urn:nbn:de:hebis:30:3-430163Test http://publikationen.ub.uni-frankfurt.de/files/43016/430_2015_Article_443.pdfTest |
| حقوق: | http://creativecommons.org/licenses/by/4.0Test/ ; info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.A09A7BD3 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1007/s00430-015-0443-9 |
|---|